Philip Morris International Financial Ratios
NYSE: PMHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Philip Morris International ratio analysis
Philip Morris International earned a net margin of 27.9% in FY 2025, up from 18.6% a year earlier. Gross margin was 67.1% compared with a median of 64.7% over the prior 9 years. At the end of FY 2025, PM traded at 22.1 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 13.7 to 27.2, with a median of 18.6.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Philip Morris International financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 22.08 | 27.00 | 18.74 | 17.42 | 16.30 | 16.04 | 18.44 | 13.69 | 27.23 | 20.42 |
| Price / sales | 6.14 | 5.01 | 4.15 | 4.94 | 4.71 | 4.49 | 4.44 | 3.65 | 5.70 | 5.32 |
| Gross margin | 67.1% | 64.8% | 63.3% | 64.1% | 68.1% | 66.7% | 64.7% | 63.7% | 63.7% | 64.8% |
| Operating margin | 36.6% | 35.4% | 32.9% | 38.6% | 41.3% | 40.7% | 35.3% | 38.4% | 40.3% | 40.9% |
| Net margin | 27.9% | 18.6% | 22.2% | 28.5% | 29.0% | 28.1% | 24.1% | 26.7% | 21.0% | 26.1% |
| Free cash flow margin | 26.2% | 28.4% | 22.4% | 30.6% | 35.7% | 32.1% | 31.0% | 27.1% | 25.6% | 25.9% |
| Return on assets (ROA) | 16.4% | 11.4% | 12.0% | 14.7% | 22.1% | 18.0% | 16.8% | 19.9% | 14.0% | 18.9% |
| Current ratio | 0.96 | 0.88 | 0.75 | 0.72 | 0.92 | 1.10 | 1.09 | 1.13 | 1.35 | 1.07 |
| Revenue growth | 7.3% | 7.7% | 10.7% | 1.1% | 9.4% | -3.7% | 0.6% | 3.1% | 7.7% | -63.9% |
| EPS growth | 60.6% | -10.0% | -13.6% | -0.3% | 13.0% | 11.9% | -9.3% | 30.9% | -13.4% | 1.4% |